美PBI  Pressure BioSciences, Inc. 
Pressure BioSciences, Inc. (PBI)美国高压生物科学公司（NASDAQ:PBIO），是世界上最专业的高压样品处理系统研发和生产厂商。该公司的总部在波士顿，其核心技术人员为麻省理工学院，哈佛大学，和耶鲁大学工作过的博士们。其研制生产的压力循环样品处理系统PCT SPS）,为生物样品前处理提供了前所未有的革命性技术。

PCT高压循环技术Pressure Cycling Technology 是一项全新、高效的生物样品制备专利。它利用多次的常压和超高（液）压（35,000 PSI或更高)之间压力快速循环，实现生物分子精准提取。可以彻底改变过去、现在和未来生物领域的各种麻烦的样品前处理，彻底改变传统的思路。广泛的应用于法医鉴定样品处理，基因组学和蛋白质组学研究样品处理，药物研发，环境科学等。


We are a life sciences company focused on the development and commercialization of a novel, enabling, platform technology called pressure cycling technology ("PCT"). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions.

Our pressure cycling technology uses internally developed instrumentation that is capable of cycling pressure between ambient and ultra-high levels at controlled temperatures to rapidly and repeatedly control the interactions of bio-molecules. Our instrument, the Barocycler®, and our internally developed consumables product line, which includes PULSE (Pressure Used to Lyse Samples for Extraction) Tubes as well as the ProteoSolveLRS™ kit for the detergent-free extraction of proteins from lipid-rich samples, together make up the PCT Sample Preparation System ("PCT SPS").

Our pressure cycling technology employs a unique approach that we believe has the potential for broad applications in a number of established and emerging life sciences areas, including;

Sample preparation for genomic, proteomic, and small molecule studies;

Pathogen inactivation;

Protein purification;

Control of chemical (enzymatic) reactions; and

Immunodiagnostics

Since we began operations as Pressure BioSciences in February 2005, we have focused substantially all of our research and development and commercialization efforts on sample preparation for genomic, proteomic, and small molecule studies.

Our business strategy is to commercialize pressure cycling technology in the area of sample preparation for genomic, proteomic, and small molecule studies ("sample preparation"). We also plan to pursue the further development and commercialization of PCT in other life sciences applications, which could include working with various strategic partners that have greater scientific, and regulatory, expertise in the respective applications than we do.